Musculoskeletal complications and aromatase inhibitors in adjuvant breast cancer treatment

被引：0
|
作者：
Khalifa, P. [1 ]
Lesur, A. [1 ]
机构：
[1] Ctr Alexis Vautrin, F-54500 Vandoeuvre Les Nancy, France
来源：
ONCOLOGIE | 2007年 / 9卷
关键词：
aromatase inhibitors; arthralgia; breast cancer hormonotherapy;
D O I：
10.1007/s10269-007-0745-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The use of aromatase inhibitors in postmenopausal patients with breast cancer have modified the pronostic and may prove to be the agents of choice in this setting. However this treatment is associated with an increased rate of short-term symptoms: articulary and muscle pain and long-term symptoms: bone loss and fractures. The decision making process is driven by the existence of these complication With the continuation of the life expectation, the prevention of the osseous iatrogenic complications must not be neglected in the care of these patients.
引用
收藏
页码：HS5 / HS10
页数：6
相关论文
共 50 条
  • [41] Aromatase inhibitors: Treatment of advanced breast cancer
    Panasci, LC
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) : 3999 - 4000
  • [42] AROMATASE INHIBITORS IN THE TREATMENT OF BREAST-CANCER
    BRODIE, AMH
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 49 (4-6): : 281 - 287
  • [43] Aromatase inhibitors: The unexpected breast cancer treatment
    Pieters, Huibrie C.
    Green, Emily
    Sleven, Miriam
    Stanton, Annette L.
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (03) : 431 - 436
  • [44] Absolute Benefits of Aromatase Inhibitors in Adjuvant Treatment of Breast Cancer: Should We Know More?
    Seruga, Bostjan
    Ocana, Alberto
    Niraula, Saroj
    Amir, Eitan
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : E346 - E347
  • [45] Aromatase, aromatase inhibitors, and breast cancer
    Chumsri, Saranya
    Howes, Timothy
    Bao, Ting
    Sabnis, Gauri
    Brodie, Angela
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2011, 125 (1-2): : 13 - 22
  • [46] Upfront adjuvant aromatase inhibitors in women with lobular breast cancer response
    van de Water, W.
    Fontein, D. B. Y.
    van de Velde, C. J. H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (15) : 3378 - 3379
  • [47] Fracture threshold in breast cancer patients treated with adjuvant aromatase inhibitors
    Bertoldo, F.
    Dalle Carbonare, L.
    Zenari, S.
    Pancheri, S.
    Zanatta, M.
    Giovanazzi, B.
    Valenti, M. T.
    Lo Cascio, V.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S161 - S161
  • [48] Genetic Underpinnings of Musculoskeletal Pain During Treatment With Aromatase Inhibitors for Breast Cancer: A Biological Pathway Analysis
    Zhu, Yehui
    Koleck, Theresa A.
    Bender, Catherine M.
    Conley, Yvette P.
    BIOLOGICAL RESEARCH FOR NURSING, 2020, 22 (02) : 263 - 276
  • [49] The role of diuretics in treatment of aromatase inhibitors induced musculoskeletal symptoms in women with non metastatic breast cancer
    Alhanafy, A. M.
    Labeeb, A. A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] UTILITY OF THE TREATMENT THRESHOLDS IN FRAX PROPOSED BY THE NOF AND THE NOGG IN PATIENTS WITH BREAST CANCER IN ADJUVANT TREATMENT WITH AROMATASE INHIBITORS
    Torre, I.
    Perez, C.
    Estopinan, L.
    Gomez, C.
    Blanco, J.
    Fernandez, O.
    Galindez, E.
    Ruiz, E.
    Galve, E.
    Arrazubi, V.
    Sala, M. A.
    Fernandez, S.
    Martinez del Prado, P.
    Ucar, E.
    Gorordo, J. M.
    Garcia Vivar, M. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 295 - 295
12345